Dr Fiona Rayner Dr Amy Anderson Dr Ken Baker Professor Christopher Buckley Dr Bernard Dyke et al. | BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study | 2021 |
|
Dr Arthur Pratt Dr Stefan Siebert Mike Cole Dr Deborah Stocken Amy Cranston et al. | Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial | 2021 |
|
Mike Cole Professor Fai Ng Dr Stefan Siebert Dr Arthur Pratt Professor John Isaacs et al. | TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis | 2021 |
|
Dr Stefan Siebert Dr Arthur Pratt Dr Deborah Stocken Dr Miranda Patterson Amy Cranston et al. | Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial | 2020 |
|
Professor Karim Raza Dr Arthur Pratt Helen Hanson Dr Stefan Siebert Professor John Isaacs et al. | Patient and researcher perspectives on facilitating patient and public involvement in rheumatology research | 2017 |
|